Johns Hopkins HIV Guide
Erythropoietin
INDICATIONS
FDA
FDA
- Anemia secondary to chronic kidney disease (CKD).
- Anemia secondary to AZT and low erythropoietin levels in HIV+ pts.
- Anemia secondary to chemotherapy.
- Reduction of allogenic blood transfusion in pts with significant blood loss during surgery.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Anemia without correctable cause in HIV+ pts w/ low erythropoietin levels (< 500 IU/L).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 4, 2016
Citation
Smith, Janessa, and Paul A Pham. "Erythropoietin." Johns Hopkins HIV Guide, The Johns Hopkins University, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545068/all/Erythropoietin.
Smith J, Pham PA. Erythropoietin. Johns Hopkins HIV Guide. The Johns Hopkins University; 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545068/all/Erythropoietin. Accessed November 4, 2025.
Smith, J., & Pham, P. A. (2016). Erythropoietin. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545068/all/Erythropoietin
Smith J, Pham PA. Erythropoietin [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2016. [cited 2025 November 04]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545068/all/Erythropoietin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythropoietin
ID - 545068
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/10/04/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545068/all/Erythropoietin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
